EyePoint, Inc. SEC filings EYPT
EyePoint, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jan 7, 2010. Its latest annual report, Form 10-K, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (results of operations, exit or restructuring costs, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 16, 2024 | — |
| CORRESP | Letter to the SEC | Aug 14, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2024 | — |
| EFFECT | Filing | Oct 30, 2023 | — |
| CORRESP | Letter to the SEC | Oct 26, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2023 | — |
| EFFECT | Filing | Aug 11, 2021 | — |
| CORRESP | Letter to the SEC | Aug 9, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 9, 2021 | — |
| EFFECT | Filing | May 7, 2021 | — |
| CORRESP | Letter to the SEC | May 5, 2021 | — |
| NT 10-K | Filing | May 3, 2021 | Dec 31, 2020 |
| SEC STAFF LETTER | Filing | Mar 5, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 18, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 4, 2021 | — |
| EFFECT | Filing | Jan 25, 2021 | — |
| CORRESP | Letter to the SEC | Jan 21, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 21, 2021 | — |
| D | Filing | Jan 6, 2021 | — |
| EFFECT | Filing | Dec 11, 2018 | — |
| CORRESP | Letter to the SEC | Dec 10, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2018 | — |
| EFFECT | Filing | Nov 1, 2018 | — |
| CORRESP | Letter to the SEC | Nov 1, 2018 | — |
| CORRESP | Letter to the SEC | Aug 17, 2018 | — |
| D | Filing | Apr 12, 2018 | — |
| D | Filing | Apr 12, 2018 | — |
| CT ORDER | Filing | Oct 2, 2017 | — |
| EFFECT | Filing | Dec 2, 2015 | — |
| CORRESP | Letter to the SEC | Dec 1, 2015 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2015 | — |
| EFFECT | Filing | Jan 23, 2013 | — |
| CORRESP | Letter to the SEC | Jan 23, 2013 | — |
| UPLOAD | Letter from the SEC | Jan 8, 2013 | — |
| CT ORDER | Filing | Feb 8, 2012 | — |
| CT ORDER | Filing | May 13, 2010 | — |
| CT ORDER | Filing | May 13, 2010 | — |
| UPLOAD | Letter from the SEC | May 12, 2010 | — |
| CORRESP | Letter to the SEC | Mar 19, 2010 | — |
| UPLOAD | Letter from the SEC | Jan 29, 2010 | — |
| EFFECT | Filing | Jan 7, 2010 | — |
| EFFECT | Filing | Jan 7, 2010 | — |
| UPLOAD | Letter from the SEC | Jan 7, 2010 | — |
| UPLOAD | Letter from the SEC | Jan 7, 2010 | — |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- EYPT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Watertown, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1314102
- Former names
- EyePoint Pharmaceuticals, Inc. (until Dec 8, 2025); pSivida Corp. (until Mar 30, 2018); pSivida LTD (until Jun 18, 2008)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Source: SEC EDGAR filings. This is company-reported data, not investment advice.